RLMD - Relmada Therapeutics Inc. (RLMD) CEO Sergio Traversa on Q3 2021 Results - Earnings Call Transcript
Relmada Therapeutics, Inc. (RLMD) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Tim McCarthy - LifeSci Advisors Sergio Traversa - CEO & Director Maged Shenouda - Chief Financial Officer Charles Ence - Chief Accounting & Compliance Officer Conference Call Participants Andrew Tsai - Jefferies Yatin Suneja - Guggenheim Securities Joon Lee - Truist Securities Andrea Tan - Goldman Sachs Jay Olson - Oppenheimer Presentation Operator Greetings and welcome Relmada Therapeutics Inc. Third Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Tim McCarthy. Tim McCarthy Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Chief Executive Officer, Sergio Traversa;
For further details see:
Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q3 2021 Results - Earnings Call Transcript